Design and Analysis of Bioavailability and Bioequivalence Studies
portes grátis
Design and Analysis of Bioavailability and Bioequivalence Studies
Chow, Shein-Chung; Liu, Jen-pei
Taylor & Francis Ltd
01/2023
756
Mole
Inglês
9781032477770
15 a 20 dias
1400
Descrição não disponível.
Preface. Preliminaries. Average Bioequivalence. Population and Individual Bioequivalence. In Vitro and Alternative Evaluation of Bioequivalence. Other Bioequivalence Studies. References. Appendices. Index.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Average Bioequivalence;Intra-subject Variabilities;bioavailability;Bioequivalence Studies;bioequivalence;Individual Bioequivalence;log-linear model;Intrasubject Variability;weighted least squares method;Average Bioavailabilities;balanced incomplete block design;YT Yr;crossover design;Higher Order Crossover Design;pharmacokinetics;Innovator Drug Product;sample size determination;Carryover Effects;meta-analysis;Generic Drug Product;Shein-Chung Chow;Population Bioequivalence;Bioequivalence Limit;Direct Drug Effect;Drug Product;Reference Formulation;Pharmacokinetic Responses;Unequal Carryover Effects;Ft FR;Aggregate Criteria;Direct Formulation Effect;Reference Products;T1 T2
Preface. Preliminaries. Average Bioequivalence. Population and Individual Bioequivalence. In Vitro and Alternative Evaluation of Bioequivalence. Other Bioequivalence Studies. References. Appendices. Index.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Average Bioequivalence;Intra-subject Variabilities;bioavailability;Bioequivalence Studies;bioequivalence;Individual Bioequivalence;log-linear model;Intrasubject Variability;weighted least squares method;Average Bioavailabilities;balanced incomplete block design;YT Yr;crossover design;Higher Order Crossover Design;pharmacokinetics;Innovator Drug Product;sample size determination;Carryover Effects;meta-analysis;Generic Drug Product;Shein-Chung Chow;Population Bioequivalence;Bioequivalence Limit;Direct Drug Effect;Drug Product;Reference Formulation;Pharmacokinetic Responses;Unequal Carryover Effects;Ft FR;Aggregate Criteria;Direct Formulation Effect;Reference Products;T1 T2
